New clinical data from 1,055 cranioplasty procedures with OssDsign Cranial PSI continue to show low complication rates
OssDsign AB (publ) (“OssDsign” or the “Company”) today announced that updated outcome data on the use of OssDsignCranial PSI in 1,055 cases of cranioplasty and cranial reconstructions have been made public via the company’s website. After a median follow-up time of 21 months, rate of infections leading to implant removal was 2.1%, which is consistent with the low levels previously presented. All data were collected as part of post-market surveillance of product performance in Europe, US and selected Asian markets in compliance with MEDDEV 2.7/1 rev.4 and MDR 2017/745.Reconstruction of
Hygiene and health company Essity is launching new ranges of washable absorbent underwear within its feminine care and incontinence products categories. The underwear offers invisible protection for up to eight hours, providing users with a more sustainable option than disposable protection.[Intimawear by Libresse]In Essity’s incontinence products category, TENA Silhouette Washable Absorbent Underwear is being launched for women with light bladder weakness and with a focus on discretion. In Essity’s feminine care category, a line of period underwear is being launched called intimawear under
